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uclear factor kappa B (NF-
 
 
 
B) has been implicated
in the regulation of cell proliferation and transfor-
mation. We investigated the role of the serum-induced
intracellular calcium increase in the NF-
 
 
 
B–dependent
cell cycle progression in Swiss 3T3 ﬁbroblasts. Noninvasive
photoactivation of a calcium chelator (Diazo-2) was used
to speciﬁcally disrupt the transient rise in calcium induced
by serum stimulation of starved Swiss 3T3 cells. The serum-
induced intracellular calcium peak was essential for sub-
sequent NF-
 
 
 
B activation (measured by real-time imaging
of the dynamic p65 and I
 
 
 
B
 
 
 
 ﬂuorescent fusion proteins),
N
 
cyclin D1 (CD1) promoter-directed transcription (measured
by real-time luminescence imaging of CD1 promoter-directed
ﬁreﬂy luciferase activity), and progression to cell division. We
further showed that the serum-induced mitogen-activated
protein kinase (MAPK) phosphorylation is calcium dependent.
Inhibition of the MAPK- but not the PtdIns3K-dependent
pathway inhibited NF-
 
 
 
B signaling, and further, CD1 tran-
scription and cell cycle progression. These data suggest
that a serum-dependent calcium signal regulates the cell
cycle via a MAPK–NF-
 
 
 
B pathway in Swiss 3T3 cells.
 
Introduction
 
The nuclear factor kappa B (NF-
 
 
 
B)/Rel family of transcrip-
tion factors consists of five members (p50, p52, p65/RelA,
c-Rel, and RelB) that form a variety of homo- or hetero-
dimeric complexes (Sen and Baltimore, 1986). NF-
 
 
 
B is
activated by its release from cytoplasmic I
 
 
 
B proteins and
subsequently translocates into the nucleus (Baeuerle and
Baltimore, 1996; Baldwin, 1996). Activation is triggered by
signal-induced phosphorylation of I
 
 
 
Bs, which targets the
inhibitors for rapid degradation by the proteasome (Thanos
and Maniatis, 1995). Several papers have suggested a role for
the NF-
 
 
 
B and I
 
 
 
B gene products in cell proliferation,
transformation, and tumor development (Rayet and Gelinas,
1999; Chapman et al., 2002).
Cell cycle activation is in part coordinated by D-type
cyclins, which are rate limiting and essential for the progression
through the G1 phase of the cell cycle (Coqueret, 2002).
Cyclin D1 (CD1) is expressed in most mammalian cells and
varies in abundance during the cell cycle, peaking in mid-G1.
The level of CD1 protein is largely controlled by the rate of
CD1 gene transcription, which is regulated by multiple
transcription factors. The CD1 promoter region includes
binding sites for NF-
 
 
 
B (Guttridge et al., 1999; Hinz et al.,
1999; Joyce et al., 1999), E2F/DP, sp-1/sp-3 (Watanabe et
al., 1998), AP-1 (Lee et al., 1999), STAT (Matsumura et al.,
1999) and CREB (Lee et al., 1999). NF-
 
 
 
B has been shown
to control cell growth and differentiation through transcrip-
tional regulation of CD1 (Guttridge et al., 1999; Hinz et al.,
1999). A nuclear NF-
 
 
 
B like DNA-binding activity has
been shown to be induced during the G0–G1 transition after
serum stimulation in mouse fibroblasts (Baldwin et al., 1991).
Despite the fact that the link between NF-
 
 
 
B and cell cycle
progression is now (at least partly) established, the upstream
events leading to NF-
 
 
 
B pathway activation upon growth
factor stimulation remain to be elucidated.
Stimulation of quiescent cells with a variety of growth factors
or mitogens induces a transient rise in the intracellular free
calcium concentration ([Ca
 
2
 
 
 
]
 
i
 
) through rapid mobilization
from both inositol 1,4,5-triphosphate stores and from the
cells’ external environment (McNeil et al., 1985; Takuwa et
al., 1995; Ichikawa and Kiyohara, 2001). Such papers have
established clear evidence for a role of [Ca
 
2
 
 
 
]
 
i 
 
in the G1/S
and G2/M phases of the cell cycle (Takuwa et al., 1995;
Cheng et al., 1996; Whitaker and Larman, 2001). However,
there have been only a few reports suggesting an important
role for [Ca
 
2
 
 
 
]
 
i 
 
at the G0–G1 transition. Regulation of the
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NF-
 
 
 
B pathway by [Ca
 
2
 
 
 
]
 
i
 
 has been studied in several mod-
els, including T-cell stimulation (Truneh et al., 1985), B
lymphocytes (Dolmetsch et al., 1998), and cerebellar gran-
ule neurons (Lilienbaum and Israel, 2003).
In the absence of growth factors, 3T3 fibroblasts enter the
G0 quiescent state. The addition of growth factors initiates
cells to enter the G1 phase of the cell cycle, the synthesis of
DNA (S phase) and cell division (M phase) (Lau and
Nathans, 1985; Bravo, 1990). During the G0–G1 transi-
tion, the expression of several transcription factors regulates
cell growth and DNA synthesis. In most cell types, the mito-
genic signal is relayed by the activation of the ubiquitously
expressed p42/p44
 
MAPK
 
 (ERK1/ERK2) (Chen et al., 1992;
Lenormand et al., 1993). Previous works have shown that
sustained activation of p42/p44
 
MAPK
 
 is required for fibro-
blasts to pass the restriction point in G1 and enter S-phase
(Pages et al., 1993; Brondello et al., 1995). The p42/
p44
 
MAPK
 
 activity has been reported to be dependent on cal-
cium concentration in a swine carotid artery model (Katoch
et al., 1999). This might suggest that p42/p44
 
MAPK
 
 could
have a role in cell cycle regulation downstream from the se-
rum-induced calcium increase. The activation of p42/
p44
 
MAPK
 
 results in the activation of a range of transcription
factors, and CD1 expression is positively regulated by this
p42/p44
 
MAPK
 
 signal (Lavoie et al., 1996).
A link between intracellular calcium increase, mitogenic
activation, and NF-
 
 
 
B pathway activation has not previ-
ously been established. In the present work, we have applied
flash photolysis of caged calcium chelator in living cells to
study the precise role of calcium in CD1 gene transcription
and subsequent cell proliferation after serum stimulation of
serum-starved Swiss 3T3 fibroblasts. We have investigated
the relationship between growth factor activation, [Ca
 
2
 
 
 
]
 
i
 
increase, MAPK and NF-
 
 
 
B activation, cell cycle gene tran-
scription, and cell cycle progression. We report that serum
stimulation of starved 3T3 fibroblasts induces a calcium-
dependent increase in p42/p44
 
MAPK
 
 phosphorylation and
NF-
 
 
 
B signaling, which in turn appears to activate CD1
gene transcription and cell cycle progression.
 
Results
 
Serum stimulation activates the NF-
 
 
 
B pathway and 
subsequent CD1 transcription
 
We investigated whether NF-
 
 
 
B regulates cell cycle entry
and CD1 transcription in Swiss 3T3 cells. Serum starvation
induced significant cell cycle arrest in 3T3 cells. 84% of cells
were in G0/G1 phase and 11% in S-phase 24 h after serum
starvation (Fig. 1 A). 18 h after serum stimulation, 44% of
the cells were in S-phase. This indicated that, as expected,
serum stimulation induced cell cycle progression in 3T3
cells. In the presence of an NF-
 
 
 
B inhibitor, Bay117082,
only 23% of cells were found to be in S-phase 18 h after se-
rum stimulation. Therefore, these data provided preliminary
evidence that NF-
 
 
 
B activation is a key step for cell cycle
progression in 3T3 fibroblasts.
To assess the role of NF-
 
 
 
B–dependent transcription in cell
cycle progression, we transfected a reporter vector, which con-
tained five copies of the NF-
 
 
 
B consensus binding site, in
front of the firefly luciferase reporter gene. Then, we used
noninvasive luminescence imaging to measure the time course
of luciferase gene expression levels. We observed a peak of lu-
minescence activity 7 h after serum stimulation (Fig. 1 B).
When the same experiment was performed using the CD1
promoter (which contains three NF-
 
 
 
B binding sites; Hinz et
al., 1999) upstream of the luciferase reporter gene, the lumi-
nescence activity reached a maximum at 3 h after serum stim-
ulation (Fig. 1 B). A second peak of luminescence was also ob-
served 20 h after serum stimulation, corresponding to the
timing of cell division and the beginning of a new cell cycle.
Analysis of endogenous CD1 mRNA levels by RT-PCR
showed an accumulation of CD1 mRNA after 4 h, which
reached a peak 8 h after serum stimulation (Fig. 1 C). This in-
crease in CD1 mRNA was inhibited by the NF-
 
 
 
B inhibitor
Bay117082 (Fig. 1 D). The serum-induced activation of CD1
promoter activity (at 6 h) was also inhibited by treatment with
Bay117082 (Fig. 2 A). In order to provide further evidence
for the direct role of NF-
 
 
 
B in serum-induced CD1 promoter
activity, we studied the effect on coexpression with the CD1
promoter of either truncated I
 
 
 
B
 
 
 
 (Fig. 2 A) or transdomi-
nant-negative IKK
 
 
 
 or IKK
 
 
 
 (Fig. 2 B). Cotransfection with
each of these expression vectors significantly repressed CD1
luciferase reporter activation, with the repression by the trans-
dominant IKK
 
 
 
 expression being particularly strong.
In order to confirm the crucial role of the NF-
 
 
 
B pathway
for serum induction of CD1 gene expression, we investigated
deletion mutants of the CD1 promoter (Fig. 2, C and D).
The 
 
 
 
1745 CD1 promoter gave 1.9-fold 
 
 
 
 0.14 (SEM) in-
duction in response to serum. A 
 
 
 
963 CD1 promoter, which
retained all three NF-
 
 
 
B sites, gave twofold 
 
 
 
 0.13 (SEM) in-
duction. A 
 
 
 
66 CD1 promoter, which had two NF-
 
 
 
B sites
deleted, gave a significantly reduced serum response (1.4-fold 
 
 
 
0.09; SEM). Most significantly, mutation of the remaining
NF-
 
 
 
B site in the 
 
 
 
66 construct further reduced the serum
response (1.14-fold 
 
 
 
 0.09; SEM).
To investigate the mechanism by which serum stimulation
activates the NF-
 
 
 
B signaling pathway, we made use of
fluorescent fusion constructs expressing the p65 Rel/NF-
 
 
 
B
protein and the inhibitor I
 
 
 
B
 
 
 
 (Nelson et al., 2002a). We
monitored p65-dsRed translocation into the nucleus and
I
 
 
 
B
 
 
 
-EGFP degradation in living cells by using time-lapse
confocal microscopy at 2-min intervals. p65-dsRed was found
to translocate into the nucleus and reached a peak nuclear
concentration 25 min after serum stimulation (Fig. 3, A and
B; Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200402136/DC1). I
 
 
 
B
 
 
 
 was found to be completely de-
graded after 15 min. The same timing of movement and deg-
radation was also observed in experiments to study the endog-
enous p65 and I
 
 
 
B
 
 
 
 proteins using Western blotting (Fig. 3
C) on nuclear extracts (for p65) and whole-cell extracts (for
I
 
 
 
B
 
 
 
). Therefore, these data suggested that the fluorescent
fusion proteins faithfully reported the dynamics of the en-
dogenous p65 and I
 
 
 
B
 
 
 
 response to serum in 3T3 cells.
 
Intracellular calcium rise is required, but not sufficient 
for serum-induced NF-
 
 
 
B activity
 
Calcium is a major second messenger that is activated during
the cell cycle and by growth factor stimulation (Means,
1994; Santella, 1998; Ichikawa and Kiyohara, 2001). We in-
vestigated how serum stimulation modulates [Ca
 
2
 
 
 
]
 
i
 
 by 
Calcium-dependent NF-
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loading the cell-permeant fluorescent dye Fluo-4-AM. Se-
rum induced an immediate and significant peak in [Ca
 
2
 
 
 
]
 
i
 
(Fig. 4 A). The transient increase in [Ca
 
2
 
 
 
]
 
i
 
 started 1 s after
serum stimulation and lasted for 30 s. No further oscillations
of [Ca
 
2
 
 
 
]
 
i
 
 were observed (over 5 min; unpublished data).
We used a calcium chelator (BAPTA-AM) to investigate the
effect of ablation of the serum-induced calcium signal on
p65-dsRed translocation. 10 
 
 
 
M BAPTA-AM was loaded
into the cells for 20 min and the cells were then stimulated
with 10% serum. Treatment with the calcium chelator led to
a drastic inhibition in the level of p65 translocation in com-
parison to control cells (Fig. 4 B). The ratio of the nuclear/
cytoplasmic fluorescence intensities reached a maximum of
1.6 in control conditions versus 0.4 in presence of BAPTA.
BAPTA can inhibit many calcium-dependent events in
cells, leading to nonspecific toxicity after 4 h. To be able to
study the long-term role of the serum-induced [Ca
 
2
 
 
 
]
 
i
 
 in-
crease, we developed a noninvasive method to abolish the
Figure 1. NF- B dependent transcription is essential for cell cycle progression. (A) Swiss 3T3 fibroblasts were serum starved for 24 h. 
They were then stimulated with 10% FCS for 18 h in the absence or presence of an NF- B inhibitor (5  M Bay117082). Cell cycle stage was 
determined by flow cytometry analysis of propidium iodide–stained cells. (B) Swiss 3T3 cells were transfected with the indicated reporter 
vectors (NF- B luc and  1745 CD1-luc). 24 h after serum starvation, firefly luciferin (Biosynth) was added to the medium (0.5-mM final 
concentration). 2 h later, serum stimulation was performed and luminescence imaging was carried out using a Hamamatsu 4880-65 liquid 
nitrogen–cooled CCD camera. Images were acquired using 30-min integration times. (C) RT-PCR analysis was performed using primers specific 
to CD1 or cyclophilin A (control), with total RNA prepared from cells stimulated with 10% FCS at indicated time points. (D) RT-PCR analysis, 
with total RNA prepared from nonstimulated starved cells (ct) or cells stimulated 8 h with 10% FCS in the presence or absence of Bay117082. 
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calcium increase, based on photoactivation of the caged cal-
cium scavenger Diazo-2, which displays a low affinity for
Ca
 
2
 
 
 
 before photolysis. This affinity is increased 30-fold af-
ter illumination at 360 nm. Diazo-2 was loaded into 3T3
cells that were then subjected to a brief (10 s) period of pho-
toactivation. This photoactivation alone induced a transient
20% decrease in [Ca
2 ]i levels (Fig. 5 A). No significant de-
crease in [Ca
2 ]i occurred in cells that were loaded with Di-
azo-2 but were not illuminated, nor in cells that were illumi-
nated but not loaded with Diazo-2 (unpublished data).
Experiments where illumination was performed immediately
after serum induction showed that the photolysis of Diazo-2
inhibited the serum-induced calcium peak (Fig. 5 B), but
had no effect on subsequent intracellular calcium levels. Pho-
toactivation of Diazo-2 after serum stimulation also blocked
detectable p65 translocation into the nucleus (Fig. 5 C) as
well as NF- B–dependent gene transcription from the NF-
 B consensus and CD1 promoters (threefold decrease; Fig. 5
D). For all these experiments, the control cells shown were
the nonilluminated fields from the same illuminated experi-
ment. Additional controls (analyzing the effects of serum
stimulation on illuminated cells that were not previously
loaded with Diazo-2) were also performed to ensure that the
lack of translocation and transcription was not due to illumi-
nation, UV-toxicity, or free radical production. These con-
trol experiments gave identical results to the nonilluminated
cells with respect to p65 translocation and reporter lumines-
cence (unpublished data). Additionally, we also analyzed the
effects of serum on cells that were loaded with Diazo-2 and
subjected to photoactivation 5 min before serum stimulation
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200402136/DC1). In this important control experi-
ment, the calcium response of the cells to the serum stimula-
tion was identical to the usual response that was obtained in
the absence of previous uncaging. Furthermore, the NF- B
translocation and NF- B–Luc responses to serum were unaf-
fected by the uncaging procedure (Fig. S1).
To further characterize the relationship between the tran-
sient [Ca
2 ]i increase and subsequent p65 activation, we per-
formed the same experiment using flash photolysis with a
Figure 2. The induction of CD1 promoter activity by serum is NF- B dependent. (A) Cells were transfected with the CD1 reporter vector. 
After a period of 24 h of serum starvation, cells were stimulated or not (ct) with 10% FCS in the absence (ct) or presence of an NF- B inhibitor 
(5  M Bay117082; 20 min preincubation), or were cotransfected with a truncated active mutant of I B . (B) Cells were cotransfected with 
the CD1 reporter vector and either a control empty vector, or a vector expressing either transdominant-negative IKK  or IKK . (C) Schematic 
diagrams of the several CD1-luciferase reporters used. (D) Cells were transfected with the indicated reporters. (A, B, and D) Results are 
expressed as fold activation relative to the level measured in nonstimulated starved cells. Cells were assayed for luciferase activity 6 h after 
serum stimulation. Histograms are means   SEM of triplicate values. Each experiment was performed three times. **, (P   0.05) indicates 
statistically significant difference (two-tailed t test).Calcium-dependent NF- B activity during cell cycle | Sée et al. 665
caged calcium donor. Photoactivation of NP-EGTA in-
duced a 22% transient increase above the resting level in
[Ca
2 ]i (Fig. 6 A). This increase was smaller, but of the same
magnitude to that obtained with serum stimulation (22%
with illumination compared to 60% above the resting level
with serum). The increase in [Ca
2 ]i after illumination
lasted for a similar duration to that obtained with serum
stimulation ( 20 s). Despite the similar dynamics in [Ca
2 ]i
levels (compared to serum stimulation), the illumination of
NP-EGTA was unable to induce any detectable p65 translo-
cation (Fig. 6 B). Together, these data (Fig. 5 and Fig. 6)
suggest that p65 translocation and downstream regulation of
gene transcription is dependent on a transient increase of
[Ca
2 ]i. However, that increase alone, without the presence
of other serum-dependent signals, was not sufficient to acti-
vate p65. Therefore, we next set out to investigate which
other factor(s) upstream of I B  degradation were activated
by growth factors and were dependent on calcium signaling.
Serum-induced NF- B activity is dependent on 
calcium-sensitive p42/p44
MAPK activity
Candidate signaling enzymes that might be involved in the
serum-induced NF- B activity were p42/p44
MAPK and Akt,
which are known to be activated during cell proliferation
(Pages et al., 1993; Davies et al., 1999), and have been re-
ported to regulate the I B/NF- B signaling pathway (Ro-
mashkova and Makarov, 1999; Madrid et al., 2001). Other
candidates were investigated including Ca-calmodulin ki-
nases (CaMKs), calcineurin, and calmodulin. Inhibition of
these either had no significant effect (cyclosporin A and
Figure 3. Serum stimulation promotes p65 translocation into the nucleus as well as I B  degradation. (A) p65-dsRed (red staining) and 
I B -EGFP (green staining) were cotransfected into Swiss 3T3 fibroblasts. 24 h after serum starvation, the cells were stimulated with 10% 
FCS. Confocal images were collected every 2 min from transfected living cells cultured in a humidified CO2 incubator (5% CO2, 37 C) 
(Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200402136/DC1). (B) Mean fluorescence intensities were measured for each 
time point in both the nucleus and cytoplasm for p65-dsRed, and the results are shown as a ratio. The I B -EGFP mean fluorescence intensities 
were measured at each time point in the cytoplasm alone and the results presented as the relative intensity to the starting fluorescence levels. 
Experiments were performed at least four times, with four fields. In each field there were typically 3–4 transfected cells. (C) Endogenous p65 
levels in the nucleus were assessed after 10% FCS stimulation for the indicated time by Western blotting nuclear extracts using an anti-p65 
antibody (1:1,000). Endogenous I B  was assessed in whole-cell extracts using an anti-I B  antibody (1:1,000).666 The Journal of Cell Biology | Volume 166, Number 5, 2004
KN93; Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200402136/DC1) or inconclusive effects (calmida-
zolium; unpublished data). We measured I B  degradation
(by Western blotting) after a 20-min pretreatment with ei-
ther the calcium chelator BAPTA-AM, the MAPK kinase
(MEK) inhibitor PD98059, or the PtdIns3k inhibitor wort-
mannin. I B  degradation was completely inhibited by
PD98059 (Fig. 7 A). A similar level of inhibition also oc-
curred in the presence of BAPTA-AM. However, wortman-
nin had no effect on I B  degradation, suggesting that
I B  degradation was calcium- and MAPK-dependent, but
not PtdIns3k dependent. When the inhibitors were applied
together, no additive effect was observed. Measurement of
I B  degradation and p65 translocation by confocal mi-
croscopy of the fluorescent fusion proteins further revealed
that I B  degradation was delayed and strongly reduced in
presence of PD98059 (50% of I B  remained versus 10%
in control cells, 100 min after serum stimulation; Fig. S4,
available at http://www.jcb.org/cgi/content/full/jcb.200402136/
DC1). The consequent p65 translocation was also abolished
in the presence of PD98059 (Fig. S4).
We further investigated both MAPK and Akt activity using
antibodies directed against phosphorylated p42/p44
MAPK
(Thr185/202/Tyr185/204) and phospho-Akt (Ser 473).
These enzymes were found to be activated by a 10-min se-
rum stimulation. p42/p44
MAPK activity was inhibited (as
expected) by PD98059, and more significantly was also in-
hibited by BAPTA-AM. However, p42/p44
MAPK activity
was not sensitive to wortmannin. Akt activity was inhibited
by all three inhibitors tested (Fig. 7 A). These data support
the hypothesis that I B  degradation is dependent on in-
creases in p42/p44
MAPK activity and that this activity is it-
self dependent on [Ca
2 ]i. However, I B  degradation was
not dependent on PtdIns3k activity, which therefore ap-
peared to act downstream from the [Ca
2 ]i increase and
MAPK activation.
Next, we investigated the order and timing of MAPK
and Akt activation after serum stimulation (by Western
blotting; Fig. 7 B). The phosphorylation of p42/p44
MAPK
was detected as early as 2 min and was complete after 5
min of serum stimulation. In contrast, Akt was weakly
phosphorylated after 5 min, and reached a maximum after
10 min. These data can be compared to the previous obser-
vations that I B  was degraded after 10 min (Fig. 3 B)
and that p42/p44
MAPK activity was sensitive to [Ca
2 ]i,
which reached a peak much earlier (1 min after stimula-
tion; Fig. 4 A). Therefore, they suggest an upstream role
for MAPK in I B  degradation.
The key role of p42/p44
MAPK in NF- B-dependent cell cy-
cle progression was further investigated by studying its role
in gene transcription and cell cycle progression. We tested
the effects of both PD98059 and wortmannin on consensus
NF- B and CD1 promoter activity. PD98059 was found to
block the serum-induced NF- B–Luc and CD1-Luc re-
porter activity (Fig. 8 A), whereas the PtdIns3k inhibitor
wortmannin gave rise to only weak inhibition of gene expres-
sion. The effect on cell cycle progression was further investi-
gated by flow cytometer analysis. In the presence of the
MEK inhibitor PD98059, 22% of cells were found to be in
S-phase after 18 h serum stimulation, compared to the con-
trol without inhibitor, where 46% of cells were in S-phase
(Fig. 8 B). These data support the concept that p42/p44
MAPK
is a key regulator of NF- B–dependent gene transcription
(specifically CD1 transcription) and subsequent cell cycle
progression.
Discussion
Rel/NF- B proteins have been shown to participate in cellu-
lar growth control and neoplasia (for review see Gilmore,
1999), and many tumor cells display constitutively high lev-
els of nuclear NF- B activity (Barth et al., 1998; Brownell et
al., 1988). The aim of the present work was to identify the
mechanism by which the NF- B pathway is activated dur-
ing cell cycle commitment. First, we demonstrated the es-
sential role of NF- B in Swiss 3T3 cell cycle progression by
inhibiting the NF- B pathway with a pharmacological in-
hibitor that blocked the cell cycle in G1 phase. This is in line
with one previous report (Hinz et al., 1999) where the cell
Figure 4. Serum-induced p65 translocation into the nucleus is 
[Ca
2 ]i dependent. (A) Starved cells were loaded with 1  M Fluo-
4-AM for 20 min at 37 C and intracellular calcium changes were 
recorded using laser scanning confocal microscopy (488-nm excita-
tion, 505–550-nm emission) in response to serum. Images were taken 
every second for 2 min, and the increase of fluorescence was calcu-
lated taking level in the control unstimulated cells as 100%. (B) 
Swiss 3T3 cells were transfected with p65-dsRed. Confocal images 
were obtained and analyzed as described above. 24 h after serum 
starvation, the cells were either stimulated with serum alone (filled 
squares) or pretreated for 10 min with 10  M BAPTA-AM (open 
circles). Experiments were performed at least four times, with four 
fields. In each field there were typically 3–4 transfected cells.Calcium-dependent NF- B activity during cell cycle | Sée et al. 667
cycle kinetics were significantly affected by stable transfec-
tion of an expression vector for DA-I B .
We confirmed the previously identified role of NF- B in
regulation of CD1 transcription (Fig. 1; Guttridge et al.,
1999; Hinz et al., 1999). The use of luminescence imaging
with a highly sensitive CCD camera allowed us to follow
CD1 and consensus NF- B promoter activities throughout
the cell cycle. We observed two peaks of CD1 promoter ac-
tivity within a 20-h interval, which appeared to correspond
to the completion of one cell cycle. The NF- B vector only
showed one luminescence peak after serum stimulation, ap-
parently indicating that the increase in NF- B activity only
Figure 5. The serum-induced [Ca
2 ]i peak is essential for NF- B–dependent signaling. (A) Starved cells were loaded with both 0.6  M 
Diazo-2 and 0.6  M Fluo-4 for 20 min at 37 C. For uncaging Diazo-2, cells were illuminated for 10 s with a Micro-point photoactivation system 
(Photonic Instruments). Intracellular calcium content was monitored every second by confocal microscopy (488-nm excitation, 505–550-nm 
emission) of Fluo-4 fluorescence. (B–D) Swiss 3T3 cells were plated on a marked dish and transfected with 0.5  g p65-dsRed and 1.5  g of 
the reporter NF- B–luc. After 24 h of serum starvation, the cells were loaded with both Fluo-4 and Diazo-2 as previously described. After one 
wash, the cells were stimulated with 10% FCS. 1 s later the cells were either illuminated for 10 s (open squares) or untreated (ct, filled squares). 
(B) Confocal microscopy was used as previously described to measure calcium content every second for 2 min. (C) p65 localization was 
assessed every 2 min for 90 min as already described. (D) An intensified CCD camera (VIM; Hamamatsu Corporation) was used to assess the 
luminescence from fields of individual control or photoactivated cells as previously described. Experiments were performed at least four times, 
with four fields. In each field there were typically 3–4 transfected cells. The horizontal line in A and B marks the period of photoactivation.668 The Journal of Cell Biology | Volume 166, Number 5, 2004
occurred in the first few hours after serum stimulation (i.e.,
at the G0–G1 transition). The small difference in timing ob-
served in the dynamics of the NF- B–luc and CD1-luc ac-
tivity (peak of activity at 7 and 3 h, respectively) was presum-
ably due to the contribution of other transcription factors to
the activity of the CD1 promoter. The timing of NF- B ac-
tivity agreed with a previous report of DNA-binding kinetics
(Baldwin et al., 1991). Therefore, these data were consistent
with the hypothesis that NF- B plays an important role in
the early G0/G1 stage of the cell cycle. Further evidence for
the role of NF- B in the regulation of CD1 transcription in
response to serum was obtained from deletion and mutation
of the NF- B sites in the CD1 promoter, which was found
to reduce serum activation, identifying the key role for these
elements in this process. Further evidence was obtained from
overexpression of a truncated IKB  or transdominant-nega-
tive IKK  and   proteins (Fig. 2 B). IKK  has recently been
shown to activate transcription of CD1 via direct activation
of Tcf in mouse embryo fibroblasts upon serum stimulation
(Albanese et al., 2003). In the absence of IKK  (IKK 
 / 
cells) the CD1 induction was delayed by about 3 h, perhaps
suggesting an upstream reinforcement mechanism by IKK 
to the control of the CD1 promoter. We used siRNA abla-
tion of p65 to attempt to show the importance of this factor
for CD1 transcription. However, we did not see any signifi-
cant affect on CD1 transcription (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200402136/DC1). Despite
good knock-down of this stable protein at the mRNA and
protein levels, some protein remained, and therefore we can-
not exclude the possibility that this was sufficient for func-
tion. It has also been shown that other NF- B family mem-
bers can activate the CD1 promoter (Guttridge et al., 1999;
Westerheide et al., 2001; Rocha et al., 2003; Romieu-Mourez
et al., 2003), and indeed the evidence for a critical role for
p65 is therefore lacking.
In the present work, we have also shown the essential role
of MAPK activity in cell cycle progression (Fig. 8 B) because
inhibition of MAPK activity with PD 98059 blocked entry
into the S-phase of the cell cycle. We observed a persistent
p42/p44
MAPK activity upon serum stimulation (at least 3 h;
Fig. 8 B), which appeared to be causally related to CD1 tran-
Figure 6. A photoactivated induced [Ca
2 ]i peak is not sufficient to 
promote p65 translocation. (A) Starved cells were loaded with both 
0.6  M NP-EGTA and 0.6  M Fluo-4 for 20 min at 37 C. For uncaging 
of NP-EGTA, cells were illuminated for 10 s with a Micro-point photo-
activation system (Photonic Instruments). Intracellular calcium content 
was monitored every second by confocal microscopy (488-nm 
excitation, 505–550-nm emission) of Fluo-4 fluorescence. (B) Subse-
quently, p65 localization was assessed every 2 min for 90 min as 
already described. The control (ct) is nonilluminated cells stimulated 
with serum. Experiments were performed at least four times, with four 
fields. In each field there were typically 3–4 transfected cells. The 
horizontal line in A and B marks the period of photoactivation.
Figure 7. I B  degradation is both [Ca
2 ]i and p42/p44
MAPK activity 
dependent. (A) I B  degradation, p42/p44
MAPK phosphorylation, 
and Akt phosphorylation were determined by Western blotting after 
10 min of serum stimulation, using antibodies directed against I B  
(1:1,000), phospho-p42/p44
 MAPK (Thr185/202/Tyr185/204; 1:5,000), 
and phospho-Akt (Ser 473; 1:5,000) and actin (1:10,000). Swiss 3T3 
fibroblasts were serum starved for 24 h before serum stimulation, 
and the pharmacological inhibitors were added, where indicated, 
20 min before the serum stimulation at the following concentrations: 
PD98059, 50  M; BAPTA-AM, 10  M; wortmannin, 100 nM. 
(B) The kinetics of p42/p44
MAPK and Akt activation were determined 
by Western blotting using anti-phospho-p42/p44
 MAPK and anti-phos-
pho-Akt antibodies. 24-h serum-starved 3T3 cells were stimulated 
by 10% FCS for indicated time points before cell lysis.Calcium-dependent NF- B activity during cell cycle | Sée et al. 669
scription (Fig. 8 A). Ryan et al. (2000) showed that p53-
induced NF- B activation can be mediated by MEK1 and
pp90
rsk,
 suggesting that MAPK signaling can directly regu-
late NF- B. Madrid et al. (2001) also reported regulation of
IKK through p38 after IL-1  stimulation. However, it is un-
likely that p38 activity has this role in serum stimulation be-
cause p38 is known to be an inhibitor of CD1 and cell cycle
progression (Lavoie et al., 1996). Therefore, we concentrated
on p42/p44
MAPK, which has been widely reported to be criti-
cal for cell cycle commitment. Our results suggest that p42/
p44
MAPK activity is an early event (2 min) after serum stimu-
lation and that it is critical for IKK phosphorylation (Fig.
S4), I B  phosphorylation (Fig. S4), and degradation (Fig.
7A; Fig. S4), and for NF- B activation (Fig. S4) and CD1
transcription (Fig. 8 A). These observations establish for the
first time a clear link between mitogenic MAPK signaling,
NF- B, CD1 transcription, and cell cycle commitment.
We investigated whether there was a link between
PtdIns3K/Akt, the NF- B pathway, and cell cycle commit-
ment in fibroblasts stimulated by serum. A significant num-
ber of previous papers have reported a link between Akt and
NF- B (Ozes et al., 1999; Madrid et al., 2001; Meng et al.,
2002). However, there remains considerable controversy
about the position of Akt in the pathway and whether it lies
upstream or downstream of the NF- B activity. Some reports
have indicated that Akt has a functional role upstream of NF-
 B and induces its activity upon TNF  stimulation (Ozes et
al., 1999) or PDGF stimulation (Romashkova and Makarov,
1999). Our results do not agree with these previous reports
because wortmannin does not inhibit I B  degradation
(even though Western blots confirm effective Akt inhibition
by this agent; see Fig. 7 A). A further paper by Meng et al.
(2002) reported that Akt could be a downstream target of
NF- B when the NF- B pathway was activated by TNF 
and lipopolysaccharides in NIH 3T3 cells. The determina-
tion of the exact position of Akt in this pathway was beyond
the objectives of this work, yet our results support a parallel or
a downstream role for Akt because the first time point of de-
tectable Akt activation was at 10 min; the same time at which
the I B  degradation was observed. Moreover, Akt was
found to be dependent on MAPK activity, but MAPK activ-
ity was independent of Akt activation (Fig. 7). We further in-
vestigated the role of Akt and MAPK on NF- B–dependent
transcription and CD1 promoter activity. MAPK inhibition
strongly blocked CD1 and consensus NF- B promoter activ-
ity, strengthening the case for an essential upstream role for
MAPK signaling (Fig. 8 A). In a significant addition to previ-
ous reports (Lavoie et al., 1996), we demonstrated for the first
time that this MAPK-dependent CD1 promoter activity oc-
curs through the NF- B pathway. The absence of any effect
of wortmannin on CD1 promoter activity conflicts with a pa-
per by Albanese et al. (2003), who reported an inhibitory ef-
fect of another PtdIns3K inhibitor, LY294002, on CD1 tran-
scription and expression in mouse embryonic fibroblasts.
We also showed the critical role of calcium signaling in
p65 translocation to the nucleus (Fig. 4). Other reports
(Takuwa et al., 1995; Ichikawa and Kiyohara, 2001) have
demonstrated that the increase in calcium is dependent on
both calcium influx through plasma membrane channels and
on calcium release from internal stores. In order to investi-
Figure 8. p42/p44
MAPK activation is 
determinant for CD1 transcription and 
further cell cycle progression. (A) Swiss 
3T3 cells were transfected with the indi-
cated reporter vectors (NF- B luc and 
 1745 CD1-luc). 24 h after serum star-
vation, cells were stimulated or not (ct) 
with 10% FCS in the absence or presence 
of MAPK inhibitor (PD98059, 50  M; 
20-min preincubation) or Akt inhibitor 
(100 nM wortmannin, 20-min pre-
incubation) as indicated. 6 h after serum 
stimulation, in vitro luciferase activity 
was measured. Histograms are means   
SEM of triplicate values. Each experi-
ment was performed three times. (B) 
Swiss 3T3 fibroblasts were serum starved 
for 24 h. 24 h after serum starvation, the 
cells were stimulated with 10% FCS for 
18 h in the absence (ct) or presence of 
PD98059 (50  M, 20-min preincubation). 
Cell cycle stage was determined by flow 
cytometric DNA histogram analysis of 
propidium iodide–stained cells.670 The Journal of Cell Biology | Volume 166, Number 5, 2004
gate the precise role of the calcium increase in response to se-
rum stimulation, we initially used calcium chelation by
BAPTA (Fig. 4 B). Subsequently, the use of flash photolysis
for the transient release of the calcium chelator Diazo-2 al-
lowed us to inhibit the serum-induced calcium increase with-
out inhibiting other calcium-dependent events in the cell.
Control experiments showed that the uncaging approach was
specific and noninvasive. First, illumination was not toxic
(cell survival was observed in three independent fields of
 20 illuminated cells, 20 h after illumination; unpublished
data). Second, the inhibitory effect on NF- B and CD1 pro-
moter activation was dependent on both illumination and on
Diazo-2 loading into the cells. Third, the illumination was
only effective when it was performed within a few seconds af-
ter serum addition to the cells. Uncaging of Diazo-2 before
or  1 min after serum stimulation had no inhibitory effect
(Fig. S1). Therefore, these control experiments showed that
only the precise experimental conditions that led to ablation
of the initial calcium peak were able to inhibit subsequent
NF- B activation and CD1 transcriptional activity.
We investigated whether a calcium-dependent protein
might activate NF- B in response to serum. The role of cal-
modulin, CaMKs, and phosphatase (calcineurin) on IKK/
I B/NF- B activity has been widely reported in different
cell models (Antonsson et al., 2003; Lilienbaum and Israel,
2003), and they were therefore candidate enzymes for trans-
ducing the serum-induced calcium signal. CaMKs and cal-
cineurin have also been reported to exert an important role
in cell cycle progression (for review see Means, 1994; San-
tella, 1998). Because CaMKIV is not expressed in Swiss 3T3
fibroblasts (unpublished data), we tested the role of CaMKII
by inhibiting its activity with the well-characterized pharma-
cological inhibitor KN93. This inhibitor had no significant
effect on serum-induced NF- B–luc transcription (Fig. S2).
We also saw no significant effect with the calcineurin inhibi-
tor cyclosporin A on serum-induced NF- B–luc transcrip-
tion in Swiss 3T3 fibroblasts (Fig. S2). It is notable that
most of the previous papers on the relationship between
these calcium effector proteins and cell cycle progression re-
port a determinant role of calcium in later stages of the cell
cycle, such as the G1/S transition (Takuwa et al., 1995) or
the G2/M transition (Patel et al., 1999), rather than at the
G0–G1 transition. Therefore, we suggest that in early stages
of the cell cycle, CaMKII or calcineurin may not be the
main effectors for the regulation of CD1 transcription.
We have demonstrated for the first time the essential role of
calcium in the regulation of CD1 transcription and for com-
mitment to cell cycle progression. We found that the early ac-
tivated mitogenic p42/p44
MAPK is calcium sensitive (Fig. 7 A),
and that in absence of the calcium signal there was no activa-
tion of the NF- B pathway (IKK phosphorylation, I B 
phosphorylation, and degradation) or subsequent NF- B–
dependent gene transcription. A calcium increase induced by
uncaging of caged calcium donor was unable to promote p65
translocation (Fig. 6) and downstream gene transcription
(unpublished data). One possible explanation for this would
be that the induced calcium increase had a different subcellu-
lar localization or dynamics compared to that induced by se-
rum. However, we felt that it was more likely that the coacti-
vation of another upstream pathway by growth factors is
needed for NF- B activation. Present data suggest that the
MAPK cascade is therefore a good candidate for this role.
In conclusion, this study of the kinetics of signaling and
transcription in living cells allowed us to understand the criti-
cal role of an early transient event (the serum-induced calcium
increase) and its later consequences for the fate of the cells.
We used state-of-the-art multiparameter noninvasive imaging
techniques to follow different biological processes occurring in
different time domains from seconds to minutes and hours in
the same cells. We propose that the G0–G1 transition is de-
pendent on both mitogenic kinase activity and on calcium sig-
naling. NF- B activation was also shown to have a critical role
in the transduction of these mitogenic signals to the nucleus.
Materials and methods
Reagents and antibodies
Tissue culture medium was from GIBCO BRL; FCS from Harlan Seralab;
pharmacological inhibitors Bay117082, PD98059, wortmannin, and
BAPTA-AM from Calbiochem; propidium iodide and ribonuclease A from
Sigma-Aldrich; and Fluo-4, NP-EGTA, and Diazo-2 from Molecular
Probes, Inc.
Antibodies to p65, I B , and phospho-Akt (ser 473) and phospho-p42/
p44
MAPK (Thr185/202/Tyr185/204) were from Cell Signaling Technology,
Inc.; anti-actin from Oncogene Research Products; HRP anti–rabbit
from Cell Signaling Technology, Inc.; and anti–mouse from Amersham
Biosciences.
Cell culture
Swiss albino 3T3 cells were grown in DME supplemented with 10% FCS
(vol/vol) and 2 mM L-glutamate at 37 C and 5% CO2. Cells (between pas-
sages 6 to 15) were plated at 10
5 cells/ml and were serum starved (0.1%
FCS [vol/vol]) 1 d after plating. 10% (vol/vol) serum stimulation was per-
formed 24 h after starvation.
Gene transfer
Plasmids. The pNF- B-luc construct (Stratagene) contains five repeats of
the NF- B consensus sequence upstream of the luciferase reporter. The
CD1-luc reporter plasmids were a gift from Dr. R. Pestell (Albert Einstein
College of Medicine, Bronx, NY; Albanese et al., 1995). p65-ds-Red and
I B-EGFP were described previously (Nelson et al., 2002a). The truncated
I B  (missing the 40 NH2-terminal amino acids) was cloned into the
pIRES2-EFGP vector (CLONTECH Laboratories, Inc.) and was from Dr. E
Costello (University of Liverpool, Liverpool, UK). Plasmids expressing the
transdominant-negative IKK  and   were a gift from Dr. N. Inohara (Uni-
versity of Michigan Medical School, Ann Arbor, MI; Tang et al., 2003).
Transfection. Cells were transfected using FuGENE™-6 (Roche) accord-
ing the manufacturer’s instructions.
Microplate luminescence assay
The cells were plated in 24-well plates and transfected on the same day in
presence of serum. After 24 h of serum starvation, the cells were treated for
6 h as described in the figure legends. Cell lysis and luminescence mea-
surements were performed as described previously (Nelson et al., 2002b),
using a plate reader (LUMIstar; BMG Lab Technologies). The experiments
were performed in triplicate.
Live-cell imaging of the luminescent reporter gene
The cells were plated onto 35-mm glass coverslip culture dishes (Iwaki),
transfected with the reporter gene, and subsequently serum starved for
24 h. The cells were then incubated on the microscope stage for 2 h at
37 C, 5% CO2, in the presence of 1 mM luciferin (Biosynth AG) and were
stimulated with 10% serum. Imaging was carried out using a microscope
(Axiovert 100; Carl Zeiss MicroImaging, Inc.) with a Fluar 20 /0.75 NA
objective. The photons emitted were collected using a CCD camera (Orca
II; Hamamatsu Corporation) cooled to  50 C. A series of images was ac-
quired using a 30-min integration time over a period of 24 h. AQM2000
software (Kinetic Imaging) was used for image acquisition and analysis. For
background correction of luminescence images, Lucida version 6 software
(Kinetic Imaging) was used to determine the darkest pixel from a compari-
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ground image (processed in the same way) was subtracted from each re-
sulting time point. This allowed for the removal of random noise, cosmic
ray events, dark current, and hot pixels. All these experiments were per-
formed at least four times, and in each experiment 5–10 cells were re-
corded and analyzed.
Fluorescence microscopy
Transfected cells in 35-mm glass coverslip culture dishes (Iwaki) were ob-
served by confocal microscopy using a microscope (LSM510; Carl Zeiss
MicroImaging, Inc.) with an F-FLUAR 40 /1.3 NA oil immersion objec-
tive. Excitation of EGFP was performed using an argon ion laser at 488 nm.
Emitted light was detected through a 505–550-nm bandpass filter from a
545-nm dichroic mirror. dsRed fluorescence was excited using a green he-
lium-neon laser (543 nm) and was detected through both a 545-nm di-
chroic mirror and a 560-nm long-pass filter. Data capture and extraction
was carried out with LSM510 version 3 software (Carl Zeiss MicroImaging,
Inc.) using tracking mode to exclude fluorescence cross talk. For the NF-
 B–EGFP fusion protein, mean fluorescence intensities were extracted for
cells at each time point for both nucleus and cytoplasm. Nuclear/cytoplas-
mic fluorescence intensity ratios were determined from these data. Con-
comitantly, the mean cellular fluorescence intensities of I B -EGFP fusion
proteins were extracted, and the fluorescence intensity relative to starting
fluorescence was determined for each cell. All these experiments were
performed at least five times, and each time four different fields, which
each contained 3–5 transfected cells, were analyzed.
Flow cytometric analysis
After serum stimulation, Swiss 3T3 cells cultured in 25-cm
2 flasks were de-
tached as a single cell suspension with 900  l trypsin. The cells were
stained by addition of 250  l of 50  g/ml propidium iodide, 0.15% Triton
X-100, and 150  g/ml RNase A before analysis in an Altra flow cytometer
(Beckman Coulter).
Calcium measurement
[Ca
2 ]i levels in living 3T3 cells were monitored by fluorescence micros-
copy using the Ca
2  indicator Fluo-4. Cells in 35-mm glass coverslip cul-
ture dishes (Iwaki) were incubated at 37 C for 20 min with the acetoxy-
methyl ester of Fluo-4 (1  M Fluo-4-AM). After washing off the excess dye,
Fluo-4–loaded cells were visualized with an F-Fluar 40 /1.3 NA oil im-
mersion objective. It was observed by time-lapse fluorescence confocal
microscopy that prolonged incubation with the fluorochrome led to a
punctuate distribution of the dye within the cells.
Flash photolysis
3T3 cells were loaded with the cell permeant acetoxy-methyl ester deriva-
tive fluorescent indicator Fluo-4 (0.7  M) and the caged calcium com-
pound nitro-phenyl-NP-EGTA (NP-EGTA; 0.7 M; Ellis-Davies and Kaplan,
1994) or Diazo-2 (Lannergren and Arner, 1992; Molecular Probes, Inc.).
Photo-release of the caged compounds was induced by a train of 4- s
flashes over a period of 10 s using 360-nm light from a micropoint photoac-
tivation system (Photonic Instruments, Inc.)
RNA extraction and RT-PCR
Total RNA was extracted by using the
 RNeasy kit (QIAGEN), following the
manufacturer’s instructions.
 2  g of RNA was used to perform reverse tran-
scriptase
 PCR (using 200 U M-MLV reverse transcriptase; Promega). For
PCR amplification, 5  l of RT products were incubated with 20 pmol of spe-
cific primers and 1 U of Taq DNA polymerase (Promega). PCR
 products
were resolved by agarose gel electrophoresis and were visualized
 by stain-
ing with ethidium bromide. The primers designed with primer 3 software
(Rozen and Skaletsky, 2000) were
 as follows: CD1: 5’-ATGCTGGTTTTTGC-
CTGAAG-3’, 5’-TTGTCCCCAATCTCCTTGTC-3’; cyclophilin A: 5’-GTG-
GTCTTTGGGAAGGTGAA-3’, 5’-TTACAGGACATTGCGAGCAG-3’.
Western blot analysis
20  g of total cell extract in sample buffer (62.5 mM Tris HCl, pH 6.8,
10% [vol/vol] glycerol, 1% SDS, 1% [vol/vol] mercaptoethanol, 0.1% bro-
mophenol blue, and protease inhibitor cocktail [Sigma-Aldrich]) was
loaded onto a 10% SDS-polyacrylamide gel. For nuclear extracts, cells
cultured on 10-cm Petri dishes were washed once with PBS 1 , and
scraped in 400  l of 0.3 M sucrose in AT buffer (AT buffer: 10 mM Tris
HCl, pH 8.0, 3 mM CaCl2, 2 mM MgCl2, 0.5 mM DTT, 0.15% [vol/vol],
and Triton X-100) and were carefully layered on 400  l 0.4 M sucrose in
AT buffer. After centrifugation at 600 g (for 10 min at 4 C), the pellet was
washed once with ice-cold pellet buffer (50 mM Tris HCl, pH 8.0, 1 mM
DTT, 0.2 mM EDTA, and 0.5 mM PMSF) and resuspended in 20  l pellet
buffer, before SDS-PAGE. A Bradford assay was performed before loading
to determine the protein concentration. Polypeptides separated by SDS-
PAGE were blotted onto a nitrocellulose membrane (0.22  m; Bio-Rad
Laboratories). Blocking and antibody incubations were performed as al-
ready described (See et al., 2001). The specific bands were detected by
ECL (West Pico; Pierce Chemical Co.). Blots were exposed to BIOMAX-MR
KODAK films. All Western blot analyses were performed at least three
times.
Online supplemental material
Fig. S1 shows controls for photoactivation of the calcium chelator Diazo-2.
Fig. S2 shows effects of CaMKII and calcineurin inhibitors on serum-induced
NF- B–dependent transcription. Fig. S3 shows the effect of siRNA knock-
down of p65 on serum-induced CD1 transcription. Fig. S4 shows the effect
of BAPTA, PD98059, and wortmannin on p-IKK and p-I B  levels and the
effect of PD98059 on I B  degradation and p65 translocation. Video 1
shows p65 translocation into the nucleus and I B  degradation after 10%
FCS stimulation.
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